版本:
中国

BRIEF-Pharma Mar says Aplidin gets orphan drug status to treat multiple myeloma in Switzerland

May 4 Pharma Mar SA:

* Aplidin receives orphan drug status for the treatment of multiple myeloma in Switzerland

* The company submitted the Marketing Authorisation Application in the European Union at the end of 2016 Source text: bit.ly/2p8zftX

Further company coverage: (Gdynia Newsroom)

我们的标准: 汤森路透“信任原则

更多 瑞士市场报道

热门文章

编辑推荐

文章推荐